Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1625 of 3173 entries
View as:

An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis

Phase: N/A Priority: Normal
NCT ID: NCT00739739 Org: User:
Start: 08/31/08 End: 01/31/10 Due: 01/31/11

Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01994668 Org: User:
Start: 01/31/14 End: 02/28/14 Due: 02/28/15

Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.

Phase: N/A Priority: Normal
NCT ID: NCT01293487 Org: User:
Start: 04/01/11 End: 05/24/12 Due: 05/24/13

A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00585195 Org: User:
Start: 04/19/06 End: 01/19/22 Due: 01/19/23

Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE)

Phase: N/A Priority: Normal
NCT ID: NCT03036813 Org: User:
Start: 12/31/16 End: 10/08/19 Due: 10/08/20

Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia

Phase: N/A Priority: Normal
NCT ID: NCT00174382 Org: User:
Start: 06/30/05 End: 04/30/08 Due: 04/30/09

A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00150241 Org: User:
Start: 02/29/00 End: 01/31/02 Due: 01/31/03

Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03903822 Org: User:
Start: 05/13/19 End: 05/07/20 Due: 05/07/21

Single Dose Study Of The Effect Of Cyclosporine On The Pharmacokinetics Of PF-04991532 In Health Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01370343 Org: User:
Start: 07/31/11 End: 07/31/11 Due: 07/31/12

A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Patch Applied To The Skin

Phase: N/A Priority: Normal
NCT ID: NCT01013454 Org: User:
Start: 12/31/09 End: 12/31/09 Due: 12/31/10

New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

Phase: N/A Priority: Normal
NCT ID: NCT00035269 Org: User:
Start: 12/31/01 End: 05/31/03 Due: 05/31/04

A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT01135511 Org: User:
Start: 07/31/10 End: 04/30/11 Due: 04/30/12

An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT00648726 Org: User:
Start: 01/31/03 End: 08/31/03 Due: 08/31/04

Study Evaluating Vabicaserin in Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00563706 Org: User:
Start: 12/31/07 End: 06/30/08 Due: 06/30/09

A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

Phase: N/A Priority: Normal
NCT ID: NCT05858749 Org: User:
Start: 06/20/22 End: 11/30/22 Due: 11/30/23

A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction

Phase: N/A Priority: Normal
NCT ID: NCT00542035 Org: User:
Start: 11/11/07 End: 02/11/08 Due: 02/11/09

A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00282971 Org: User:
Start: 03/06/06 End: 02/19/08 Due: 02/19/09

A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00825084 Org: User:
Start: 02/28/09 End: 05/31/09 Due: 05/31/10

Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age

Phase: N/A Priority: Normal
NCT ID: NCT01768117 Org: User:
Start: 02/28/13 End: 02/28/14 Due: 02/28/15

Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00243503 Org: User:
Start: 02/28/06 End: 07/31/10 Due: 07/31/11

CP-690,550 And Oral Contraception Drug-Drug Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT01137708 Org: User:
Start: 06/30/10 End: 07/31/10 Due: 07/31/11

A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05567887 Org: User:
Start: 11/02/22 End: 10/02/24 Due: 10/02/25

Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00879684 Org: User:
Start: 01/31/08 End: 04/30/11 Due: 04/30/12

Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00913458 Org: User:
Start: 09/30/09 End: 12/31/12 Due: 12/31/13

A Phase 1 Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03162900 Org: User:
Start: 06/09/17 End: 10/16/17 Due: 10/16/18